Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions

Ma, Chen, Hong, Fenfang, Yang, Shulong·2022·Molecules
DOI 10.3390/molecules27041210

Cited by (243)

Items 201–243 of 243

  1. Research Progress on Plasma Biomarkers of Alzheimer’s Disease
    泠羽 陈 · 2025 · Advances in Clinical Medicine
  2. Synthesis and biological evaluation of some pyrimidine derivatives as multifunctional ligands for the treatment of Alzheimer's disease
    Orhan Öztürk, Özlem Oyardı, Rahşan Ilıkçı Sağkan, Yasemin Dündar · 2025 · Bioorganic & Medicinal Chemistry
  3. Spatiotemporal profiling of functional network overlapping modules in Alzheimer’s disease
    Yue Gu, Ying Yi Lin, Liangfang Li, Junji Ma, Sihan Wei, Zhengjia Dai, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Network Neuroscience
  4. The association of late-life depressive symptoms with brain amyloid-β deposition: the ARIC-PET study
    Sylee Kanetkar, Valerie N. Morrill, Marco T. Egle, Keenan A. Walker, Dean Foster Wong, Rebecca F. Gottesman · 2025 · Aging Brain
  5. Molecular Dynamics Study and Prediction of Oral Toxicity of Calebin A in Alzheimer’s Disease
    Franciane Nunes de Souza, Gabrieli Santos Oliveira, A. G. Silva, Leonardo Bruno Federico, Carlos Henrique Tomich de Paula da Silva, Carlton Anthony Taft, Lorane Izabel da Silva Hage-Melim · 2025 · Series in bioengineering
  6. The Role of Glucagon-like Peptide-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: A Literature Review of Clinical Trials
    Joanna Pilśniak, Julia Węgrzynek‐Gallina, Błażej Bednarczyk, Aleksandra Buczek, Aleksandra Pilśniak, Tomasz Chmiela, Agnieszka Jarosińska, Joanna S. Siuda, Michał Tadeusz Holecki · 2025 · Life
  7. C3 lowering in adult APP KI mice rescues synapses and spares cognitive decline
    Brijendra Bahadur Singh, André F. Batista, Emma T. Spooner, Brianna R. Colletti, Takaomi C. Saido, Michael C. Carroll, Cynthia Ann Lemere · 2025 · Molecular Neurodegeneration Advances
  8. Innovative Approach: The Role of Acetylcholinesterase Immunotherapy in Alzheimer’s Treatment
    Payal N. Vaja, Harsh H madiya, Siddhi K. Upadhyay, Dilip R. Ghusar, Vivek P. Solanki, Chetan H. Borkhataria · 2025 · Asian Journal of Pharmacy and Technology
  9. Aloe-emodin attenuates Aβ25−35-induced HT22 cell pyroptosis via inhibiting NLRP3 inflammasome pathway
    Huawu Gao, Shifeng Yang, Zhaorong Ouyang, Yuan Wang, Jiaxuan Tang, Qirui Hou, Ziyi Fang, Nan Shao, Biao Cai · 2026 · 3 Biotech
  10. Research Progress on Targeted Inhibition of Ferroptosis and Alzheimer's Disease Treatment
    Annan Liu, Jianhui Li, Wei Gao, Xue Li, Jing Song, Liping Xing, Honglin Li · 2026 · Mini-Reviews in Medicinal Chemistry
  11. Single-cell machine learning uncovers genetically anchored, cell-type specific programs of Alzheimer’s disease
    Adithya V. Madduri, Randall J. Ellis, Chirag M. Lakhani, David A. Bennett, Chirag J. Patel · 2026 · medRxiv
  12. Hesperetin Early Intervention Reduces Β-Amyloid Production in APP/PS1 Mice by Decreasing Beta and Gamma-Secretase Enzyme
    Hao Wen, Yifeng Dong, Ruiting Wang · 2026 · CNS & Neurological Disorders - Drug Targets
  13. Overexpression of PGRMC2 in astrocytes improved cognitive function in a mouse model of Alzheimer’s disease by modulating neuroinflammation
    Taiyang Zhu, Chao Zhou, Hui Zhou, Fanyu Shen, Shang Wang, Yan Zhou, Guoliang Jin, Jie Zu, Xu Yang, Hongjuan Shi et al. · 2026 · Journal of Translational Medicine
  14. Identifying Age-Related Protein Mechanisms of Alzheimer's Disease Amyloidosis from Cerebrospinal Fluid Proteomics Using a Novel Machine Learning Approach
    Justin Melendez, Leila Mozaffar, Ziqiao Jiao, Kaleigh F. Roberts, Carlos Cruchaga, Miranda E. Orr, Andrew S.J. Yoo, Suzanne E. Schindler, John Budde, Jigyasha Timsina et al. · 2026 · Research Square
  15. Radiofrequency-Induced Disassembly of Insulin Fibrillar Structures Using Functionalized Magnetic Nanoparticles
    Natália Andrýsková, Veronika Benková, Melánia Babincová, Peter Babinec, Stefan DURDIK · 2026 · Applied Sciences
  16. Evolutionarily conserved signaling intermediate in Toll pathways facilitates exercise-induced amelioration of skeletal muscle atrophy by maintaining mitochondrial quality control in middle-aged mice
    Jingcheng Fan, Xin Wen, Xuemei Duan, Xue Zhang, Tan Zhang · 2026 · The Journals of Gerontology Series A
  17. The Mechanism of PANoptosis in Alzheimer’s Disease: Exploring the Multiple Network Regulation of Cell Death
    Huan Wei, Binchuan Wang, Jie Yang, Lishang Liao · 2026 · Frontiers in Bioscience-Landmark
  18. Alkaloids from In Vitro Cultured Rhodophiala pratensis Display Neuroprotective Effects in Murine Microglial Cell Models of Inflammation
    Diana Correa-Otero, Nandis Fiallos, Ángela Gómez-Mediavilla, Manuela García López, Carlota Siguero-Gómez, Luis Alejandro Bustamante-Salazar, Julio Alarcón, Edgar Pastene · 2026 · Plants
  19. Case Studies and Patents in Alzheimer’s Disease Research
    Deepak Kumar, Piyush Anand, Juhi Tiwari, S. N. Singh · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  20. Salidroside mitigates cognitive deficits in AlCl3 exposed aging mouse by modulating APP processing and mitochondrial dysfunction
    Yiru Dong, Huiling Jin, Shengmin Wang, Yanji Xu · 2026 · Frontiers in Behavioral Neuroscience
  21. Insights into the Comprehensive Role of Free Radicals in the Development of Alzheimer’s Disease: A Review
    Shireen Ansari, Ayushi Khali, Bhuwan Chandra Joshi, Sushmita Uniyal · 2026 · Physiological Mini Reviews
  22. Luteolin and neuroinflammation: a multi-target therapeutic strategy for central nervous system disorders
    Jianting Huang, Miaomiao Yu, Yanan Zou, Lezhen Wang, Yuan Ma, Yue Ma, Xiangyi Kong, Fei Rong · 2026 · Frontiers in Pharmacology
  23. Application of Plasma Metabolomic Biomarker Panels in Early Diagnosis and Disease Staging of Alzheimer’s Disease
    Jieqiong Chen, Xuhui Chen, Ting Chen, Jun Hu · 2026 · Metabolites
  24. ПРИМЕНЕНИЕ КОНФОКАЛЬНОЙ ВИЗУАЛИЗАЦИИ И ИММУНОГИСТОХИМИЧЕСКОГО АНАЛИЗА ПРИ ИЗУЧЕНИИ ВЛИЯНИЯ АЛЬДЕГИДОГЕННЫХ ЛИПИДОВ НА ВЫВЕДЕНИЕ Aβ-АМИЛОИДА У МЫШЕЙ
    Семячкина-Глушковская Оксана Валерьевна, Elena I. Saranceva, Искра Татьяна Дмитриевна · 2026 · NATURAL SCIENCES
  25. Peptide vaccination for Alzheimer's disease: Immunological foundations, therapeutic potential, and translational barriers
    Haoteng Chen, Y Y Lin, DeZhi Kang, Tong Zhao · 2026 · Journal of Alzheimer s Disease Reports
  26. Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening
    Jiajun Huang, Chaohong Da, Shengrui Zhai, Xingyan Yao, Meiling Zhang, Tao Zhang · 2026 · Assay and Drug Development Technologies
  27. A Narrative Review of Amyloid-β Monoclonal Antibodies for Alzheimer Disease
    Richard J. Caselli, David Geldmacher, Traci Schilling · 2026 · The Neurologist
  28. Research Progress on the Anti-Inflammatory and Antioxidant Effects of Daidzein: Its Mechanisms of Action in Related Diseases, and Related Nanoformulations to Enhance Its Bioavailability
    Xinxin Chen, Di Han, Gang Wang, Yanhong Wang, Guan Feng · 2026 · Antioxidants
  29. Exploring the Relationship Between Hearing Loss and Cognitive Dysfunction from the Perspective of Molecular Mechanisms
    Lu Wang, Ziqi Zhou, Xingqian Shen, Guolei Wu, X Y Chen, Bo Liu, Hongjun Xiao · 2026 · Biomolecules
  30. Molecular chaperones modulate the amyloid-β aggregates in Alzheimer’s disease
    Subashchandrabose Chinnathambi · 2026 · Advances in protein chemistry and structural biology
  31. Targeting IL-33 in Precision Neuroimmunology: Cellular Mechanisms and Therapeutic Strategies for CNS Disorders
    Lili Li, Shuting Wang, Lian Duan, Li Zhang, Hongmu Yan, Yue Zhu, Luyang Tao, Y. N. Gao · 2026 · Journal of Neuroimmune Pharmacology
  32. Functional Implications of Marine Biosurfactants and Their Therapeutic Potential Against Alzheimer's Disease
    Zainab Irfan, Shakti Ketan Prusty, Sumon Giri, Arijit Nandi, Mostafa Gouda · 2026 · Food Science & Nutrition
  33. Engineering ApoE3-Targeted NIR-Responsive Liposomes for Multimodal Inhibition of Amyloid-β Aggregation and Acetylcholinesterase Activity
    Shubham Kumar Singh, Harsh Dinodiya, Shivay Parihar, Chiranjeevi Korupalli, Raviraj Vankayala · 2026 · ACS Chemical Neuroscience
  34. Intranasal L-DOPA/TPP-engineered extracellular vesicles deliver icariin to ameliorate mitochondrial dysfunction with associated sphingolipid remodeling in Alzheimer's disease models
    Beibei Wu, Junyong Wu, Lemei Zhu, An Li, Yangbo Fu, Zuchao Lei, 吴大花, Weijun Peng, Le Xie · 2026 · Materials Today Bio
  35. Advances in nanomaterial-based biomarker detection for neurodegenerative diseases: Special focus on Alzheimer’s and Parkinson’s disease
    Shajahan Azeez, Raj Kumar Chinnadurai, Saravanaraman Ponne, Durairaj Duraikkannu · 2026 · International review of neurobiology
  36. Design, Synthesis, In Vitro Biological Evaluation, and In Silico Analyses of Novel Pyrano[3,4- b ]indole-Containing Compounds as Promising Multitarget Candidates for Alzheimer’s Disease and Cancer Therapy
    Ferah Cömert Önder, Alper Önder, Kadircan Ural, Merve Sıkık, Khaled A. N. Abusharkh, Bülent Özpolat, Mehmet Ay · 2026 · ACS Omega
  37. Mitochondria–endoplasmic reticulum contact sites (MERCS/MAM): Multi-layered upstream regulators of microglial senescence in Alzheimer’s disease
    Annan Liu, Liping Xing, Jianhui Li, Wei Gao, Mingyuan Yao, Jing Song, Honglin Li · 2026 · Ageing Research Reviews
  38. Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer’s and Parkinson’s Disease
    Angélica P. Ríos-Gallardo, Daniela Herrera-Ramírez, Sussy Bastias Candia, Nibaldo C. Inestrosa · 2026 · Molecules
  39. ALZHEIMER’S DISEASE - ETIOPATHOGENESIS, CLINICAL PRESENTATION, AND CURRENT DIAGNOSTIC METHODS - A LITERATURE REVIEW
    Mateusz Cieciora, Małgorzata Kawiorska, Julia Surowiec, Aleksandra Cieciora, Katarzyna Zegadło, Katarzyna Jolanta Kuc, Maciej Dobrucki, Krzysztof Brzezicki, Patryk Jakubiak, Wiktoria Ruta Bełcikowska-Skowron · 2026 · International Journal of Innovative Technologies in Social Science
  40. Molecular and genetic basis of alzheimer’s disease and emerging treatment Modalities
    Himanshi Varshney, Yasir Hasan Siddique · 2026 · Neurodegenerative Disease Management
  41. Protein glycosylation and glycation in Alzheimer's disease: mechanisms, crosstalk, and therapeutic perspectives
    LUO Yuqi, Jingjing Gu · 2026 · Frontiers in Neuroscience
  42. Liver-derived FGF21 contributes to protection against Alzheimer’s disease pathogenesis
    Rabab Al‐Lahham, Qaiss Dweik, Sravan G.S. Sreenivasa Murthy, Satkarjeet Kaur Gill, Balaji Krishnan, Silvana Valdebenito, Eliseo A. Eugenín, Cornelis J. Elferink · 2026 · NeuroImmune Pharmacology and Therapeutics
  43. Synthesis, Biological Evaluation, Molecular Docking, Molecular Dynamics Simulation, Enzyme Kinetic Studies, and In silico Pharmacokinetic Evaluation of Novel Benzimidazole–Pyrazoline Derivatives as Dual Cholinesterase Inhibitors
    Elif Ergin, Nurdan Ebru Irmak, Gökçe Seyhan, İsmail Çeli̇k, Burak Barut, Gülgün Ayhan‐Kılcıgil · 2026 · Polycyclic aromatic compounds